NVWM LLC
ARQT icon

NVWM LLC’s Arcutis Biotherapeutics ARQT Stock Holding History

NVWM LLC’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.4K Hold
1,000
– – 0.01% 309
2026
Q2 		$26.2K Hold
1,000
– – 0.01% 261
2026
Q1 		$23.6K Hold
1,000
– – 0.01% 270
2025
Q4 		$29K Hold
1,000
– – 0.01% 262
2025
Q3 		$18.8K Buy
+1,000
New +$15.8K ﹤0.01% 293

Other funds holding ARQT

Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
OpenArc Corporate Advisory
OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

NVWM LLC's ARQT Position: Q3 2026 in Review

NVWM LLC held its Arcutis Biotherapeutics (ARQT) position steady in Q3 2026 at 1,000 shares worth $26.4K. The position accounts for 0.01% of the portfolio, ranked #309.

NVWM LLC first reported a position in ARQT in Q3 2025 and has held it in 5 quarters since. The position peaked at $29K in Q4 2025. 43 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • NVWM LLC held 1,000 shares of Arcutis Biotherapeutics worth $26.4K as of Q3 2026.
  • NVWM LLC left its Arcutis Biotherapeutics share count unchanged in Q3 2026.
  • Arcutis Biotherapeutics made up 0.01% of NVWM LLC's portfolio in Q3 2026, its #309 holding.
  • NVWM LLC first reported a position in Arcutis Biotherapeutics in Q3 2025 and has held it in 5 quarters since.
  • NVWM LLC's Arcutis Biotherapeutics position peaked at $29K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on NVWM LLC's 13F filing for Q3 2026, filed 14 Oct 2026.